Sanofi-aventis is a diversified global healthcare company, focused on patients' needs. The leading pharmaceutical company in Europe and in emerging markets, sanofi-aventis is the fourth largest worldwide (source IMS 2008). The Group's vaccine division, sanofi pasteur, is the world leader for human caccine production and commercialization.

A worldwide presence, market leadership in vaccines, major biological products and a strong and long-established presence in emerging markets: these are the core strengths of sanofi-aventis. Company business activities also include consumer healthcare products, generics and animal health products.

Our business strategy is based on three key themes to reach and deliver sustainable growth: - increasing innovation in Research and Development. - adapting out structures to meet the challenges of the future, - exploring external growth opportunities.

Sanofi-aventis Research and Development strategy will be increasingly focused on key technologies and diseases, providing the best response to patients' needs. Sanofi-aventis explores new avenues of research; partnerships with other companies (in the field of biotech-nologies, nanotechnologies, bio markers...) to identify the best projects and bring new medicines to market.

As a healthcare leader, sanofi-aventis is concerned about global public health issues and implements a regional approach to markets to make the most of local opportunities.

For More Information:
Sanofi-aventis Gulf Office
Dubai Health Care City
Al Razi Bldg., 5th Floor, Main ntrance 5008
P.O. Box 53899 DUBAI
Tel.: +971 4 4299200 - Fax: +971 4 4298 255

Visit Our Website: www.sanofi-aventis.ae , kw.sanofi-aventis.com , qa.sanofi-aventis.com , ye.sanofi-aventis.com , om.sanofi-aventis.com , bh.sanofi-aventis.com